AstraZeneca PLC AZN shares slid 1.34% to £114.52 Monday, on what proved to be an all-around rough trading session for the ...

British-Swedish drug maker has gone from Beijing’s scrutiny to its praise, hailed as a sign of doing business in China.

The investments come amid an ongoing investment fraud probe into AstraZeneca’s former China head Leon Wang—and despite ...

Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” fourth quarter 2024 ...

AstraZeneca boosts cancer therapies push with ... a positive outcome in the development of the therapy key to the company's pipeline. February 24, 2025 FTSE 100 flat as investors await speeches ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

AstraZeneca Plc will invest $2.5 billion in a new research center in Beijing, in a major show of commitment to China just ...

AstraZeneca PLC AZN shares slid 1.69% to £116.08 Friday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100 Index UKX falling 0.63% to 8,646.79.

The drugmaker plans to build a research-and-development center in Beijing and strike deals with local biotechnology companies ...

AstraZeneca makes a deal to buy another biotech company, this one with a price tag that could reach $1 billion.

AstraZeneca has entered the “off-the-shelf” cell therapy space, penning a $1 billion deal to acquire EsoBiotec and its ...

Harbour BioMed inks collaboration with AstraZeneca to discover and develop next-generation therapeutic antibodies: Shanghai & Rotterdam, The Netherlands Tuesday, March 25, 2025, 1 ...